![](https://endpts.com/wp-content/uploads/2017/06/shutterstock_635671628.jpg)
Nanjing Legend wows ASCO researchers with early data on a BCMA-targeted CAR-T contender
China’s Nanjing Legend Biotech is a virtual unknown in the CAR-T field. But it gained marquee status at ASCO today with stellar early multiple myeloma …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.